WHAT IS ZOLGENSMA?
ZOLGENSMA is the only one-time SMA treatment to delivers lasting outcomes (>10 years) with a single dose, vs competitors with life-long treatment burden.
The goal:
Greater focus on patient-centric storytelling, highlighting the impact of Zolgensma on developmental milestones.
Visual and thematic emphasis on progress.
A refreshed visual identity that distinguishes Zolgensma more clearly from competitors, while remaining consistent with existing brand elements.
Core Visual
Secondary Messaging
Support Assets
